UCB's Cimzia touted as potential top-seller

Belgium's UCB is riding high today after it won the FDA nod for a new indication for Cimzia as a rheumatoid arthritis remedy. Company officials and some analysts said the drug could be an up-and-coming blockbuster. Report

Suggested Articles

Vaccines
Vaccines

Inovio, Moderna score CEPI funding for coronavirus work

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

by Eric Sagonowsky
artists conception 2019
Manufacturing

Real estate group creating gene therapy CDMO at former GSK site

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

by Eric Palmer
amgen
Pharma Asia

Amgen amps up in Asia with full control of Astellas Japanese JV

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.

by Angus Liu